Evidence map›Paper›PMID 35169570›Full record

ArticleEuropean journal of case reports in internal medicine2022

Do We Have a Culprit? An Association of Giant Cell Arteritis with Pulmonary Embolism.

Carolina Miguel Gonçalves, Pedro Neves Tavares, Fátima Saraiva, João Morais, Maria Jesus Banza

Open access · goldAbstract read
In one paragraph

Article in European journal of case reports in internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Giant cell arteritis initially presents as pulmonary embolism.Rheumatology and immunology research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Carolina Miguel GonçalvesCentro Hospitalar de Leiria, Leiria, Portugal.
Pedro Neves TavaresCentro Hospitalar de Leiria, Leiria, Portugal.
Fátima SaraivaCentro Hospitalar de Leiria, Leiria, Portugal.
João MoraisCentro Hospitalar de Leiria, Leiria, Portugal.
Maria Jesus BanzaCentro Hospitalar de Leiria, Leiria, Portugal.
Instituto Politécnico de Leiria · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell arteritis is the most common type of systemic vasculitis. An increased risk of venous thromboembolism has been described in these patients. We report the case of a 79-year-old woman with a history of polymyalgia rheumatica, who presented with left thoracic pain radiating to the neck and scapula plus temporal headache. She had no changes on physical examination, but work-up tests showed increased D-dimer levels and computed tomography pulmonary angiography revealed signs of a chronic/subacute embolism in the right inferior lobe. Anticoagulation with edoxaban was started after 5-day bridging with enoxaparin. Three weeks after the initial diagnosis the headache still persisted and she developed scalp tenderness. Giant cell arteritis was diagnosed and treated with prednisolone, with complete resolution of symptoms. Extensive diagnostic work-up was performed to identify an alternative cause of pulmonary thromboembolism; however, the investigations were negative. This case supports the hypothesis that this type of vasculitis could be related to the occurrence of pulmonary embolism. LEARNING POINTS: An increased risk of thromboembolism has been associated with giant cell arteritis.Early diagnosis is crucial; however, the role of antiplatelets or anticoagulants is not yet established.

Indexed as

Giant cell arteritispulmonary embolism

Identifiers

PMID35169570
PMCPMC8833303
OpenAlexW4226133453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.